{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:40:06Z","timestamp":1791906006807,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cardfail.2024.12.016","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T14:55:45Z","timestamp":1739372145000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acute Heart Failure: Transitioning From Symptom-Based Care to Remission"],"prefix":"10.1016","volume":"32","author":[{"given":"GAD","family":"COTTER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BETH A.","family":"DAVISON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DOUGLAS L.","family":"MANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN","family":"BIEGUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOZINE M.","family":"TERMAATEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MATTEO","family":"PAGNESI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YONATHAN","family":"FREUND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADRIAAN A.","family":"VOORS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PIOTR","family":"PONIKOWSKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARCO","family":"METRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALEXANDRE","family":"MEBAZAA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2024.12.016_bib0001","doi-asserted-by":"crossref","first-page":"G3","DOI":"10.1093\/eurheartj\/suw042","article-title":"Heart failure: a historical perspective","volume":"18","author":"Ferrari","year":"2016","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0002","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0003","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-8703(56)90099-0","article-title":"A study of C-reactive protein in the serum of patients with congestive heart failure","volume":"51","author":"Elster","year":"1956","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0004","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.CIR.37.6.900","article-title":"Hemodynamic effects of diuresis at rest and during intense upright exercise in patients with impaired cardiac function","volume":"37","author":"Stampfer","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1056\/NEJM198309293091302","article-title":"Evaluation of a new bipyridine inotropic agent\u2013milrinone\u2013in patients with severe congestive heart failure","volume":"309","author":"Baim","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0006","unstructured":"Medical Transactions, vol. 3. 1785. College of Physicians, London. Transaction XVI, 255\u201386"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0007","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-8703(50)90299-7","article-title":"The discovery of the organic mercurial diuretics","volume":"39","author":"Vogl","year":"1950","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0008","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0735-1097(99)00027-3","article-title":"A view from the millennium: the practice of cardiology circa 1950 and thereafter","volume":"33","author":"Silverman","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0009","unstructured":"White PD. Heart Disease, 4th ed. New York, NY: MacMillan, 1951."},{"key":"10.1016\/j.cardfail.2024.12.016_bib0010","doi-asserted-by":"crossref","unstructured":"Lang HJ, Hropot M. 1995. Discovery and development of diuretic agents. In: Greger RF, Knauf H, Mutschler E (eds.) Diuretics. Handbook of Experimental Pharmacology, vol 117. Berlin, Heidelberg, Germany: Springer.","DOI":"10.1007\/978-3-642-79565-7_4"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0011","first-page":"328\u201444","article-title":"Zur Chemie des Furosemids. I. Synthesen von 5-sulfamoyl-anthranilsaure-Derivaten","volume":"99","author":"Sturm","year":"1966","journal-title":"Chern Ber"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0013","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1388-9842(02)00017-X","article-title":"Acute heart failure: a novel approach to its pathogenesis and treatment","volume":"4","author":"Cotter","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0014","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjmed.2003.11.025","article-title":"Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000","volume":"116","author":"Lee","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000330409","article-title":"Neurohormonal activation in acute heart failure: results from VERITAS","volume":"119","author":"Milo-Cotter","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0016","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0002-9149(03)00545-9","article-title":"Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes","volume":"92","author":"Milo","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0017","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ejhf.2077","article-title":"Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF","volume":"23","author":"Davison","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0019","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/CRD.0b013e3181ceff67","article-title":"History of right heart catheterization: 100 years of experimentation and methodology development","volume":"18","author":"Nossaman","year":"2010","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI101570","article-title":"Measurement of cardiac output in man using the technique of catheterization of the right auricle or ventricle","volume":"24","author":"Cournand","year":"1945","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031745","article-title":"Acute heart failure is a malignant process: but we can induce remission","volume":"12","author":"Cotter","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2017.05.008","article-title":"Acute heart failure is an event rather than a disease: plea for a radical change in thinking and in therapeutic drug development","volume":"6","author":"Packer","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0023","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ejhf.3162","article-title":"Medical therapy of cardiogenic shock: contemporary use of inotropes and vasopressors","volume":"26","author":"Riccardi","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0024","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/ejhf.2629","article-title":"Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock: a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC)","volume":"24","author":"Metra","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchf.2019.09.012","article-title":"Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial","volume":"8","author":"Cox","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0026","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41569-024-00997-0","article-title":"Contemporary pharmacological treatment and management of heart failure","volume":"21","author":"Bozkurt","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0028","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.118.039331","article-title":"clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril\/valsartan or enalapril in the PIONEER-HF trial","volume":"139","author":"Morrow","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0029","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0031","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0032","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jacc.2024.04.055","article-title":"Effects of rapid uptitration of neurohormonal blockade on effective, sustainable decongestion and outcomes in STRONG-HF","volume":"84","author":"Biegus","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0033","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ejhf.2920","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial","volume":"25","author":"Arrigo","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2882","article-title":"Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: insights from the STRONG-HF trial","volume":"25","author":"\u010cerlinskait\u0117-Bajor\u0117","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0035","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.jacc.2023.03.426","article-title":"Uptitrating treatment after heart failure hospitalization across the spectrum of left ventricular ejection fraction","volume":"81","author":"Pagnesi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0036","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/ejhf.3074","article-title":"Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure","volume":"25","author":"Ter Maaten","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0037","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/eurheartj\/ehad335","article-title":"NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial","volume":"44","author":"Adamo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0038","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ejhf.3174","article-title":"Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: insights from the STRONG-HF trial","volume":"26","author":"Pagnesi","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0039","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cardfail.2023.09.002","article-title":"Safety indicators in patients receiving high-intensity care after hospital admission for acute heart failure: the STRONG-HF trial","volume":"30","author":"Tomasoni","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0040","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.cardfail.2023.05.015","article-title":"POINT: Should new drug development in heart failure focus on patients discharged from an acute heart failure admission? Lessons from recent studies","volume":"29","author":"Cotter","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0041","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0042","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0043","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12872-023-03149-3","article-title":"Effect of C-reactive protein on the risk of heart failure: a Mendelian randomization study","volume":"23","author":"Habibi","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0044","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cardfail.2014.02.002","article-title":"High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial","volume":"20","author":"Kalogeropoulos","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2016.10.038","article-title":"Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction","volume":"226","author":"Boulogne","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1235178","article-title":"Inflammation in acute heart failure","volume":"10","author":"Garofalo","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0047","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1388-9842(02)00121-6","article-title":"Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH","volume":"4","author":"Coletta","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0048","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/FJC.0000000000000378","article-title":"Interleukin-1 blockade in acute decompensated hart failure: a randomized, double-blinded, placebo-controlled pilot study","volume":"67","author":"Van Tassell","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0049","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004373","article-title":"Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)","volume":"10","author":"Van Tassell","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0050","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0051","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/FJC.0000000000000048","article-title":"Cardiac outcome prevention effectiveness of glucocorticoids in acute decompensated heart failure: COPE-ADHF study","volume":"63","author":"Liu","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0052","first-page":"865","article-title":"Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance","volume":"23","author":"Liu","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0053","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/ehf2.13926","article-title":"Effect of systemic corticosteroid therapy for acute heart failure patients with elevated C-reactive protein","volume":"9","author":"Mir\u00f3","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0054","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/ejhf.3452","article-title":"Burst steroid therapy for acute heart failure: the CORTAHF randomized, open-label, pilot trial","volume":"26","author":"Cotter","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0055","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/ejhf.3300","article-title":"Colchicine in acute heart failure: rationale and design of a randomized double-blind placebo-controlled trial (COLICA)","volume":"26","author":"Pascual-Figal","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0056","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1015355112501","article-title":"Angiotensin II as an inflammatory mediator: evolving concepts in the role of the renin angiotensin system in the failing heart","volume":"16","author":"Mann","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0057","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mce.2011.06.038","article-title":"Aldosterone, mineralocorticoid receptor, and heart failure","volume":"350","author":"Messaoudi","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0058","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cardiores.2004.02.005","article-title":"Cross-regulation between the renin angiotensin system and inflammatory mediators in cardiac hypertrophy and failure","volume":"63","author":"Sekiguchi","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0059","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1523-1755.2005.00424.x","article-title":"NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria","volume":"68","author":"Takase","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0060","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000015603.84788.47","article-title":"Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway","volume":"105","author":"Kalra","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0061","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.CIR.0000081768.13378.BF","article-title":"Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor","volume":"108","author":"Flesch","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0062","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-024-02294-z","article-title":"Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure","volume":"23","author":"Wang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0063","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12933-024-02210-5","article-title":"Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study","volume":"23","author":"Guo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0064","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/ijms20071698","article-title":"Cross-talk between neurohormonal pathways and the immune system in heart failure: a review of the literature","volume":"20","author":"De Angelis","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41569-023-00919-6","article-title":"Immunomodulation and immunopharmacology in heart failure","volume":"21","author":"Markousis-Mavrogenis","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0066","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101641","article-title":"Glucagon-like peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction","volume":"66","author":"McLean","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0068","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat Inflam"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0069","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2024.08.028","article-title":"Inflammation in obesity-related HFpEF: the STEP-HFpEF program","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0071","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3181\/00379727-141-36894","article-title":"Acute alteration of plasma renin activity by large doses of intravenous prednisolone","volume":"141","author":"Katz","year":"1972","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0072","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1152\/ajplegacy.1969.217.5.1396","article-title":"Effects of corticosteroids on plasma angiotensinogen and renin activity","volume":"217","author":"Nasjletti","year":"1969","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0073","first-page":"267","article-title":"The effect of prednisone on plasma norepinephrine concentration and renin activity in salt-depleted man","volume":"77","author":"Kelsch","year":"1971","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0074","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0002-9149(03)00658-1","article-title":"Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure","volume":"92","author":"Fung","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0075","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ejhf.1342","article-title":"Effects of sacubitril\/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study","volume":"21","author":"Nougu\u00e9","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0076","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0077","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cardfail.2011.09.003","article-title":"Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific)","volume":"18","author":"Atherton","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0078","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1801291","article-title":"Effects of serelaxin in patients with acute heart failure","volume":"381","author":"Metra","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0079","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jchf.2016.09.013","article-title":"Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations","volume":"4","author":"Joyce","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/clc.23313","article-title":"Cardiac changes associated with vascular aging","volume":"43","author":"Singam","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0081","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fphar.2018.00904","article-title":"New Insights in Cardiac \u03b2-Adrenergic Signaling During Heart Failure and Aging","volume":"9","author":"de Lucia","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170733","article-title":"The renin-angiotensin system and cardiovascular autonomic control in aging","volume":"150","author":"Miller","year":"2022","journal-title":"Peptides"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0083","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0084","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030603","article-title":"Clonal hematopoiesis of indeterminate potential from a heart failure specialist's point of view","volume":"12","author":"Sikking","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0085","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ejhf.1167","article-title":"Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction","volume":"20","author":"Packer","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0086","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jacc.2024.08.028","article-title":"Inflammation in obesity-related HFpEF: the STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0087","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.cardfail.2024.12.016_bib0088","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10741-011-9261-3","article-title":"Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome","volume":"17","author":"Colombo","year":"2012","journal-title":"Heart Fail Rev"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:35:16Z","timestamp":1768296916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1071916425000466"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.12.016","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Heart Failure: Transitioning From Symptom-Based Care to Remission","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}